WallStSmart
TVRD

Tvardi Therapeutics, Inc.

NASDAQ: TVRD · HEALTHCARE · BIOTECHNOLOGY

$3.15
+2.94% today

Updated 2026-04-30

Market cap
$30.02M
P/E ratio
P/S ratio
559.61x
EPS (TTM)
$-3.26
Dividend yield
52W range
$3 – $44
Volume
0.0M

Tvardi Therapeutics, Inc. (TVRD) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
+51.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+85.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-5.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-6.3%
2026-03-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-31$-0.78-36.8%$3.20$3.00-6.3%
2025-11-13$-0.59+27.2%$4.24$4.03-5.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.57$-0.78-36.8%
2025-09-30$-0.81$-0.59+27.2%
2025-06-30$-0.39$0.51+230.8%
2025-03-31$-0.58$-0.50+13.8%$2.57M+20.3%
2024-12-31$-0.20$-5.21-2548.7%$1.46M-51.6%
2024-09-30$-0.24$-8.19-3312.2%$2.56M-47.5%
2024-06-30$-0.26$-0.27-3.8%$991000.00
2024-03-31$-0.40$-0.56-40.0%$2.13M
2023-12-31$-0.45$-0.59-31.1%$3.00M
2023-09-30$-0.52$-0.52+0.0%$4.87M
2023-06-30$-0.54$-0.58-7.4%
2023-03-31$-0.51$-0.49+3.9%
2022-12-31$-0.32$-0.56-75.0%

Frequently asked questions

Has Tvardi Therapeutics, Inc. beaten earnings estimates?
Tvardi Therapeutics, Inc. has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of +51.0% over the last 4 quarters.
How does TVRD stock react to earnings?
TVRD stock has moved an average of -5.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.